Influenza virus causes major epidemics of respiratory disease. Influenza is characterised by an abrupt onset of fever, myalgia, headache, sore throat and acute cough, and can cause extreme malaise lasting several days. Primary viral pneumonia occurs rarely, but secondary bacterial pneumonia frequently complicates influenza in individuals whose medical condition makes them vulnerable to the disease. Such persons are high risk in epidemics and may die of pneumonia or cardiac complications.
Recommendations
Annual immunisation in autumn is recommended for individuals in the following groups: Annual immunisation in autumn should be considered for individuals in the following groups who have increased risk from disease (not free vaccine):
• Adults and children (greater than 6 months old) with chronic lung and heart disorders. This includes children with cystic fibrosis and congenital heart disease. The influenza vaccine is recommended for those asthmatics who require frequent hospitalisations (not free); • Adults and children (greater than 6 months old) with other chronic illness requiring regular medical follow up or hospitalisation in the preceding year; • Residents of nursing homes (free to nursing homes); • Children and teenagers (6 months to 18 years) on long term aspirin therapy who maybe at risk of developing Reyes syndrome after influenza. 
Any person who wishes to reduce the likelihood of becoming ill with influenza

Dosage and Frequency
Vaccination is best undertaken from 1 March in anticipation of winter outbreaks of influenza. A single dose is sufficient for persons who have been exposed to viruses of similar antigenic composition to the strain or strains present in the vaccine.
There is no evidence that influenza vaccine is effective in infants under the age of 6 months of age. Children under 5 years of age should be vaccinated with care because of the risk of febrile reactions. • Fever, malaise and flu like symptom occur occasionally. These reactions can commence a few hours after the vaccination. And may last up to 2 days. The symptoms mimic influenza but as the vaccine is not a live vaccine do not cause influenza.
Cost
Uncommon
• Immediate adverse events such as acute allergic reaction are a rare consequence of the vaccine. The allergy is usually due to a component of the vaccine manufacturing process such as egg protein.
• There have been cases of Gillian Barre Syndrome (sudden onset of paralysis) being associated with the influenza vaccine. The incidence is 1:1,000,000 and therefore the risk of complications of the influenza virus in at risk individuals is higher than contracting Gillian Barre Syndrome • Paracetamol is recommended for the fever and painful vaccination site, associated with vaccination.
